<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-0eba195e=""><div class="content_outer_container" data-v-0eba195e=""><div class="share_preview_container" data-v-0eba195e=""><div class="dialog_list" data-v-0eba195e=""><div class="dialog_item" data-v-0eba195e=""><div class="dialog_question fir_dialog_question" data-v-0eba195e=""><div class="question_con" data-v-0eba195e=""><h1 class="fir_question_content" data-v-0eba195e="">
                                    How did Xeris Biopharma's revenue and expenses trend in Q4 2024?
                                </h1> <div class="user_slot" data-v-0eba195e=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-0eba195e=""> <span class="user_desction" data-v-0eba195e="">
                                        
                                        5/9/2025 08:19am
                                    </span></div></div></div> <div class="seo-text-answer" data-v-0eba195e="">Xeris Biopharma's revenue for Q4 2024 was $60.1 million, while the specific expenses for the quarter were not provided. However, the absence of expense data does not necessarily imply that the company had no expenses, only that the data is not available for that particular quarter.


|code|Ticker|Name|Date|Total Revenue|Total Expenses|market_code|
|---|---|---|---|---|---|---|
|XERS|XERS.O|Xeris Biopharma|2024 Q1|4.0638E7||185|
|XERS|XERS.O|Xeris Biopharma|2024 Q2|4.8065E7||185|
|XERS|XERS.O|Xeris Biopharma|2024 Q3|5.4268E7||185|
|XERS|XERS.O|Xeris Biopharma|2024 Q4|6.0099E7||185|

</div> <div class="dialog_answer" data-v-0eba195e=""><div class="dialog_content" data-v-0eba195e=""><div class="answer_content" data-v-0eba195e=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-261d488f=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-261d488f=""> <div class="recommend-part" data-v-7790c618="" data-v-261d488f=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai,aj,ak,al,am,an,ao,ap,aq,ar,as,at,au,av){return {layout:"default",data:[{noData:c,currentQuestion:g,textDescription:T,comeFrom:"AInvestShareLink",events:[],answerSource:o}],fetch:{},error:p,state:{sharePreviewModule:{loadJgySuccess:d,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:h,agent_id:a,output_media_info:[],task_id:a,language:a,source:o,cache_builder:a,reply_action:"Answer",execute_mode:G,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"How did Xeris Biopharma's revenue and expenses trend in Q4 2024?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"How did Xeris Biopharma's revenue and expenses trend in Q4 2024?\",\"user_id\":\"dp64385087\",\"user_name\":\"\",\"trace_id\":\"0a9814d3-5609-4466-a7a9-7ed330b94ad2\",\"session_id\":\"0a9814d3-5609-4466-a7a9-7ed330b94ad2\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:"query_data",query_type:j,text:"1 results found:\n|stock code|stock name|Last Price|Last Change|Total Revenue[20241231]|Total Expenses[20241231]|Report End Date|\n|---|---|---|---|---|---|---|\n|XERS|Xeris Biopharma|$5.16|15.18%|$60.1 million||20241231|\n",query_data:{number:h,title:H,query_type:j,condition:a,model_sql:U,data_ext_params:{merge_repeat:c,expand_index:b,data_add:h,add_index:d}}}],answer_chain_name:V,agent_mode:W,native_answer:a,come_from:a,text_answer:T,trace_id:i,cost:15108,event_names:a,question:g,fallback_type:X,input_type:Y,fall_back_reason:{fall_back_type:X,may_fall_back_reason:"UNKNOWN",risk_detail:{matched_words:[]}},session_id:i,first_return_cost:2761,cache_type:"no_cache",question_id:i,transfer_question:g,signal_type:"ON_COMPLETE",start_time:I,remote_svc:o,slots:[],answer_type:G,user_id:y,skill_name:J},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:i,session_id:i,user_id:y,question:g,source:o,raw_question:g,version:"3.4.1",action_name:J,nlu:{entity:[{type:Z,value:q,market:k}]},output_time:I,deep_research:c,deep_thinking:c,agent_mode:W},extra:{}},{answer_path:z,section:{id:A,info_texts:["Thinking"],show_type:B,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"begin"},logs:[],extra:{is_deep_research:c,deep_thinking:c}},{answer_path:z,section:{id:A,info_texts:["Querying Stock: XERS Revenue (Q4 2024), Expenses (Q4 2024)"],show_type:B,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"thinking"},logs:[],extra:{action:"Querying Stock",action_input:H,thought:"The user seeks to analyze Xeris Biopharma's (XERS) revenue and expense trends in Q4 2024. I should focus on XERS's revenue and expense data for Q4 2024. I will use FinQuery for the data mentioned above."}},{answer_path:e,section:{id:r,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:r,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:z,section:{id:A,info_texts:["Generating Answer"],show_type:B,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"ongoing"},logs:[],extra:{}},{answer_path:e,section:{id:s,info_texts:[],show_type:C,voice_txt:"X",text_answer:_,rich_text:_,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:2000,info_texts:[],show_type:C,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{title:H,query_type:j,trace_data:a,index:h,model_sql:U,data_ext_params:{merge_repeat:c,expand_index:b,data_add:h,add_index:d},jump_type:"data_query"}],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:r,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:r,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:r,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:s,info_texts:[],show_type:C,voice_txt:".\n\n",text_answer:$,rich_text:$,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:t,market_id:k,name:m,domain:Z},pos:d,section_id:s,txt:m,jump_type:"pos_fenshi"}],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:s,info_texts:[],show_type:aa,choice:[],result_page:{components:[{uuid:"e5d4a032e30d0b81",config:{score:16,show_type:ab,scoreRuleNames:"value_unit;data_size;",showDataZoom:b,show_type_id:101,title:"柱状图",render:{x:u,y:[D]},title_config:{config:{display:b,display2:c,txt_style:d,url:a},data:{h1:ac,h2:a},show_type:K}},data:{chunks_info:"[]",code_count:h,columns:[{index_name:L,key:L,label:"hq_code",source:M,type:f},{domain:E,feKey:N,index_name:N,key:N,label:L,origin_index:"stock code",source:M,type:f,unit:a},{domain:E,feKey:O,index_name:O,key:O,label:"name",origin_index:"stock name",source:M,type:f,unit:a},{feKey:u,index_name:u,key:u,label:"date",origin_index:u,type:"DATE"},{domain:E,feKey:D,index_name:D,key:D,label:a,source:a,timestamp:a,type:ad,unit:ae},{domain:E,feKey:P,index_name:P,key:P,label:a,source:a,timestamp:a,type:ad,unit:ae},{index_name:af,key:af,type:f}],condition:"[{\"sonSize\":4,\"opName\":\"and\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@stock code\",\"indexProperties\":[\"EQUAL XERS.O\"],\"indexPropertiesMap\":{\"EQUAL\":\"XERS.O\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0},{\"sonSize\":2,\"opName\":\"or\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@Total Expenses\",\"indexProperties\":[\"起始交易日期 20240101\",\"截止交易日期 20241231\"],\"indexPropertiesMap\":{\"起始交易日期\":\"20240101\",\"截止交易日期\":\"20241231\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@Total Revenue\",\"indexProperties\":[\"起始交易日期 20240101\",\"截止交易日期 20241231\"],\"indexPropertiesMap\":{\"起始交易日期\":\"20240101\",\"截止交易日期\":\"20241231\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0}]",dataSize:4,datas:[{code:t,"Total Revenue":40638000,Ticker:q,market_code:k,Date:"2024 Q1",Name:m},{code:t,"Total Revenue":48065000,Ticker:q,market_code:k,Date:"2024 Q2",Name:m},{code:t,"Total Revenue":54268000,Ticker:q,market_code:k,Date:"2024 Q3",Name:m},{code:t,"Total Revenue":60099000,Ticker:q,market_code:k,Date:"2024 Q4",Name:m}],meta:{extra:{}},row_count:h,status_code:d,status_msg:"ok"},category:"generic",chart_type:"bar",show_type:ab,title_config:{config:{display:b,display2:c,txt_style:d,url:a},data:{h1:ac,h2:a},show_type:K},support_refresh:b,data_config:{query:a,query_type:j,data_ext_params:{}}}],global:{query_type:j},page:{language:a,layout:{layout_data:"[{\"children\":[],\"showType\":\"bar3\",\"uuid\":\"e5d4a032e30d0b81\"}]"},render_for:Q},data_config:{query:a,query_type:j,data_ext_params:{}}},tag_info_list:[],is_last:c,uuid:"bd9afab0-6d33-4260-a8c6-45702f8bae2e"},logs:[],extra:{}},{answer_path:e,section:{id:s,info_texts:[],show_type:C,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:z,section:{id:A,info_texts:["Completed"],show_type:B,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:aa,choice:[{display_text:v,query_text:v,trace_info:{item_id:"17a4f288005206c606f354f07ced7477",item_type:n,item_name:v,rec_info:ag}},{display_text:w,query_text:w,trace_info:{item_id:"44befb173c2778d87e61098322fb09b0",item_type:n,item_name:w,rec_info:ah}},{display_text:x,query_text:x,trace_info:{item_id:"252796aa29cdae2733b827eb0dbd075e",item_type:n,item_name:x,rec_info:ai}}],result_page:{components:[{show_type:"lowcode",title_config:{show_type:K,data:{h1:a,h2:a},config:{display:c,txt_style:d,type:"1",display2:c,url:a}},request_config:[{source_type:aj,related_name:ak}],puuid:R,tag:a,category:"custom",uuid:al}],global:{urp_static_data:[{name:ak,value:{status_code:d,columns:[{type:f,index_name:am,key:am},{type:f,index_name:an,key:an},{type:f,index_name:ao,key:ao},{type:f,index_name:ap,key:ap},{type:f,index_name:aq,key:aq}],datas:[{send_text:v,item_type:n,rec_info:ag,display_text:v,rec_reason:a},{send_text:w,item_type:n,rec_info:ah,display_text:w,rec_reason:a},{send_text:x,item_type:n,rec_info:ai,display_text:x,rec_reason:a}],dataSize:aj,status_msg:a}}],lowcode_type:"shunda",interface_request_list:[],lowcode_json:{stack:c,visible:b,childLimit:9999,label:ar,type:"thslc\u002Fthslc-common-container",leaf:c,animate:[],version:"1.0.1",script:[],props:[],path:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js",isTransparent:b,style:{"background-color":a,"box-shadow":"0px 0px 0px",color:a,width:F,"min-height":"100%",position:as,height:F},isMaterial:c,id:ar,needTheme:c,hasEditor:c,packed:c,events:[],child:[{readmeUrl:"https:",stack:c,visible:b,customStyle:a,childLimit:d,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:b,version:"1.12.0",animate:[],url:S,componentUuid:al,script:[{name:at,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:b,renderType:"blue"},path:S,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:S},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:"block",width:F,position:as,height:F},isMaterial:b,_id:19,id:at,hasEditor:b,packed:c,events:[],isSetDefaultValue:b}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:Q,voice_txt:a,tracking_info:{},uuid:R},order:{is_auto:c,render_for:Q,chart_type:"command",puuid:R}},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1003,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{action_name:J,with_paid_index:c,no_refresh_answer:c,answer_source:{agent_id:a,agent_name:a,execute_mode:G,answer_chain_name:V},is_deep_research:c,deep_thinking:c,create_time:1746749990267},is_last:b}],questionItem:{data:{qStr:g,encodeFlag:c,imageData:p,docsData:[],quoteData:p},tplType:"question"},events:au,agentId:a,param:{entity_info:{},add_info:{ori_question:g},event_list:au,client_ip:a,question:g,user_id:y,user_name:a,trace_id:i,session_id:i,source:o,input_type:Y}}],userId:y,userName:a,startTime:I,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:p,endSignal:c,theme:"white",showTracePopup:c,traceListData:[],chatTraceTargetIndex:d,traceTableData:p,showMask:c}},serverRendered:b,routePath:"\u002Faime\u002Fshare\u002Fhow-did-xeris-biopharmas-revenue-and-expenses-trend-in-q4-2024-51c18a\u002F",config:{_app:{basePath:av,assetsPath:av,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",true,false,0,"other\u002FopenAnswer","STR","How did Xeris Biopharma's revenue and expenses trend in Q4 2024?",1,"0a9814d3-5609-4466-a7a9-7ed330b94ad2","intusstock","185","signal","Xeris Biopharma","llm_generated","ths_ainvest_lite_web",null,"XERS.O",999,2001,"XERS","Date","What were Xeris Biopharma's revenue figures for Q4 2024?","What was the net income of Xeris Biopharma for Q4 2024?","How did Xeris Biopharma's cash flow from operations change in Q4 2024?","dp64385087","progress\u002Fsearching_for",1000,"searching_for","rich_text","Total Revenue","abs_国际美股领域","auto","agent","XERS Revenue (Q4 2024), Expenses (Q4 2024)",1746749975159,"review stocks","title1","code","fixed_index","Ticker","Name","Total Expenses","aigc","39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","Xeris Biopharma's revenue for Q4 2024 was $60.1 million, while the specific expenses for the quarter were not provided. However, the absence of expense data does not necessarily imply that the company had no expenses, only that the data is not available for that particular quarter.\n\n\n|code|Ticker|Name|Date|Total Revenue|Total Expenses|market_code|\n|---|---|---|---|---|---|---|\n|XERS|XERS.O|Xeris Biopharma|2024 Q1|4.0638E7||185|\n|XERS|XERS.O|Xeris Biopharma|2024 Q2|4.8065E7||185|\n|XERS|XERS.O|Xeris Biopharma|2024 Q3|5.4268E7||185|\n|XERS|XERS.O|Xeris Biopharma|2024 Q4|6.0099E7||185|\n\n","select   stock_code,   total_revenue,   total_expenses from   ustock_fin_data where   report_end_date = date('2024y4q')   and stock_code = 'XERS.O'","agent_common_v2\nagent-summary","normal_agent","NONE","typewrite","stock","Xeris Biopharma's revenue for Q4 2024 was $60.1 million, while the specific expenses for the quarter were not provided. However, the absence of expense data does not necessarily imply that the company had no expenses, only that the data is not available for that particular quarter[^1]",".\n\n\n``` visual\n{\"uuid\":\"bd9afab0-6d33-4260-a8c6-45702f8bae2e\"}\n```","result_page","bar3","XERS Total Revenue","DOUBLE","USD","market_code","2+679_496_21_554+0+0+0a9814d3-5609-4466-a7a9-7ed330b94ad2+17a4f288005206c606f354f07ced7477+llm_generated+aimeTagAnalysis+0+0.01769503392279148+1","2+679_496_21_554+0+0+0a9814d3-5609-4466-a7a9-7ed330b94ad2+44befb173c2778d87e61098322fb09b0+llm_generated+aimeTagAnalysis+0+0.015954263508319855+2","2+679_496_21_554+0+0+0a9814d3-5609-4466-a7a9-7ed330b94ad2+252796aa29cdae2733b827eb0dbd075e+llm_generated+aimeTagAnalysis+0+0.006224135402590036+3",3,"recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","root","relative","iwencai\u002FrecommendList0326",Array(0),"\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/b929a16.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/28ccbec.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/d9802b5.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/2077034.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/1e0f8d6.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7a5f495.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/921844b.js" defer=""></script>